D Pyne|D A Isenberg - JoVE Visualize

Showing results (331-340 of 431) with videos related to

Pageof 44

Sort By:

Annals of the Rheumatic Diseases|October 27, 2007

B cell depletion therapy in systemic lupus erythematosus: relationships among serum B lymphocyte stimulator levels, autoantibody profile and clinical responseG Cambridge, D A Isenberg, J C W Edwards, et al.

Annals of the Rheumatic Diseases|September 24, 1999

Ro/SSA and La/SSB specific IgA autoantibodies in serum of patients with Sjögren's syndrome and systemic lupus erythematosusN Pourmand, M Wahren-Herlenius, I Gunnarsson, et al.

Lupus|February 1, 1994

Identification and characterization of a new human DNA reactive monoclonal antibody and a common idiotype, WRI 176 Id betaF Blanco, C Longhurst, R Watts, et al.

Clinical and Experimental Rheumatology|September 1, 1992

Disease activity in systemic lupus erythematosus: report of the Consensus Study Group of the European Workshop for Rheumatology Research. II. Identification of the variables indicative of disease activity and their use in the development of an activity score. The European Consensus Study Group for Disease Activity in SLEC Vitali, W Bencivelli, D A Isenberg, et al.

British Journal of Rheumatology|June 1, 1988

Successful treatment of Raynaud's syndrome with Iloprost, a chemically stable prostacyclin analogueD A Yardumian, D A Isenberg, M Rustin, et al.

Analytical Chemistry|March 9, 2012

In situ electrokinetic enhancement for self-assembled-monolayer-based electrochemical biosensingMandy L Y Sin, Tingting Liu, Jeffrey D Pyne, et al.

Lupus|January 17, 2003

Disturbances in peripheral blood B cell subpopulations in autoimmune patientsK N Potter, C I Mockridge, A Rahman, et al.

Lupus|August 30, 2003

The prevalence and clinical significance of autoantibodies to plasminogen activator inhibitor 1 in systemic lupus erythematosusR L Bates, S J Payne, S L Drury, et al.

International Journal of Immunopharmacology|January 1, 1981

Cyclosporin A for the treatment of systemic lupus erythematosusD A Isenberg, M L Snaith, W J Morrow, et al.

Clinical and Experimental Immunology|June 17, 2005

Natural killer cell activity in families of patients with systemic lupus erythematosus: demonstration of a killing defect in patientsM R J Green, A S M Kennell, M J Larche, et al.

Pageof 44

Showing results (331-340 of 431) with videos related to

Sort By:

Pageof 44

Annals of the Rheumatic Diseases|October 27, 2007

B cell depletion therapy in systemic lupus erythematosus: relationships among serum B lymphocyte stimulator levels, autoantibody profile and clinical responseG Cambridge, D A Isenberg, J C W Edwards, et al.

Annals of the Rheumatic Diseases|September 24, 1999

Ro/SSA and La/SSB specific IgA autoantibodies in serum of patients with Sjögren's syndrome and systemic lupus erythematosusN Pourmand, M Wahren-Herlenius, I Gunnarsson, et al.

Lupus|February 1, 1994

Identification and characterization of a new human DNA reactive monoclonal antibody and a common idiotype, WRI 176 Id betaF Blanco, C Longhurst, R Watts, et al.

Clinical and Experimental Rheumatology|September 1, 1992

Disease activity in systemic lupus erythematosus: report of the Consensus Study Group of the European Workshop for Rheumatology Research. II. Identification of the variables indicative of disease activity and their use in the development of an activity score. The European Consensus Study Group for Disease Activity in SLEC Vitali, W Bencivelli, D A Isenberg, et al.

British Journal of Rheumatology|June 1, 1988

Successful treatment of Raynaud's syndrome with Iloprost, a chemically stable prostacyclin analogueD A Yardumian, D A Isenberg, M Rustin, et al.

Analytical Chemistry|March 9, 2012

In situ electrokinetic enhancement for self-assembled-monolayer-based electrochemical biosensingMandy L Y Sin, Tingting Liu, Jeffrey D Pyne, et al.

Lupus|January 17, 2003

Disturbances in peripheral blood B cell subpopulations in autoimmune patientsK N Potter, C I Mockridge, A Rahman, et al.

Lupus|August 30, 2003

The prevalence and clinical significance of autoantibodies to plasminogen activator inhibitor 1 in systemic lupus erythematosusR L Bates, S J Payne, S L Drury, et al.

International Journal of Immunopharmacology|January 1, 1981

Cyclosporin A for the treatment of systemic lupus erythematosusD A Isenberg, M L Snaith, W J Morrow, et al.

Clinical and Experimental Immunology|June 17, 2005

Natural killer cell activity in families of patients with systemic lupus erythematosus: demonstration of a killing defect in patientsM R J Green, A S M Kennell, M J Larche, et al.

Pageof 44